As we found a significant decrease in the expression of GRIN2B expression in the FXS patient neurons (also observed in the FMR1 KO neurons), we tested the NMDA response on the FXS patient cells compared to controls. This evidence concerns the gene GRIN2B and fragile X syndrome.